Ultragenyx Faces Another Setback as FDA Denies Approval for Gene Therapy Targeting Sanfilippo Syndrome

Ultragenyx Faces Another Setback as FDA Denies Approval for Gene Therapy Targeting Sanfilippo Syndrome